Catheters Market

Catheters Market Size:

The global catheters market size reached US$ 22.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032. The growing demand for minimally invasive procedures, increasing surgical procedures, expanding healthcare infrastructure, and the rising number of chronic illnesses such as stroke, heart disease, cancer, and chronic lung disease are contributing to the market growth.

Catheters Market Analysis:

• Major Market Drivers: The increasing number of chronic disorders consisting of kidney disorders, cardiovascular diseases, and urine incontinence, and recent technological developments have led to the creation of minimally invasive procedures and modern catheter designs which is contributing to market growth.
• Key Market Trends: Specialty catheters developed for particular medical procedures, including urinary, cardiovascular, and neurovascular catheters are gaining traction. The prominent development in the market is the increasing popularity of antimicrobial-coated catheters to lower the risk of infections related to catheterization procedures.
• Geographical Trends: Developed areas with complex healthcare infrastructure, high healthcare costs, and precious reimbursement systems, such as North America and Europe, lead the market growth. Moreover, the rising economies in Latin America and Asia-Pacific are intensifying quickly due to better healthcare facilities, growing healthcare expenditure, and rising patient awareness.
• Competitive Landscape: Some of the major market players in the catheters industry include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Coloplast Corporation, ConvaTec Group PLC, Edwards Lifesciences Corporation, Hollister Incorporated, Johnson & Johnson, Medtronic plc, Stryker Corporation, Teleflex Incorporated, among many others.
• Challenges and Opportunities: The risk of catheter-associated infections is one of the major obstacles in the market, which has led to the development of catheter materials and coatings that are resistant to infection. In addition, catheters in areas other than standard care, such as research and veterinary medicine, and in developing catheters for younger and older patients are creating opportunities.

Catheters Market Drivers:

Chronic disease prevalence

The prevalence of chronic diseases is on the rise, with statistics indicating a significant global burden. According to the World Health Organization (WHO), chronic diseases constitute 49% of the global disease burden and 61% of all deaths, or 35 million deaths. The global burden of disease is predicted to reach 56% by 2030, with 70% of all casualties internationally allocated to chronic ailments. Africa and the Eastern Mediterranean are expected to see the biggest increases which will continue to drive the market further.

Growing Demand for Minimally Invasive Procedures

Several individuals, patients, and healthcare specialists are going for minimally invasive techniques due to their better patient outcomes, faster recovery times, and lower risk of problems. These actions are inclined to concern smaller cuts than conventional open procedures, resulting in briefer recovery periods, less pain after the procedure, and a lower chance of difficulties. Moreover, patients who have less invasive processes habitually experience better esthetic results and a quicker return to their usual routines. As a result, there has been a substantial rise in the need for medical supplies like catheters, which are crucial for simplifying certain procedures.

Rising Surgical Procedures

The cumulative number of surgical procedures, optional and emergency, is driving the demand for catheters. According to data from the American College of Surgeons, approximately an estimated 4 million patients undergo emergency general surgery procedures each year, representing about 11% of all surgical procedures and reckoning for almost a quarter of overall inpatient costs, indicating a substantial need for catheters in various surgical interventions. As a result, the rising product demand is creating a positive market outlook across the globe.

Development of Healthcare Infrastructure

The development of medical devices such as catheters and access to essential medical services and technologies is becoming important as countries commit to grow and modernizing their health systems. According to national health expenditure data, the expenditure for Medicare grew by 5.9% to $944.3 billion in 2022, or 21 percent of total NHE. Governments and private sector organizations are triggering investments in the construction of new hospitals, clinics, and hospitals and the renovation of existing ones in regions such as Asia-Pacific, Latin America, and Africa. Major prospects for the global catheters market are indicated by increasing infrastructure development, which also aims to address health disparities, improve patient care, and meet the growing health needs of a growing population.

Catheters Market Opportunities:

Innovation in Product

Innovation plays a pivotal role in driving the growth of the catheters market. Companies are relentlessly investing in research and development (R&D) to announce innovative catheter designs and patterns that improve performance and patient outcomes. For instance, the development of antimicrobial-coated catheters has significantly downgraded the risk of catheter-associated infections, enhancing patient safety. Furthermore, advancements in catheter technology, such as the introduction of hydrophilic coatings for easier insertion and removal, contribute to the market's expansion.

Investment in the Healthcare Industry

The healthcare industry is experiencing a rise in investment from both public and private sources, which is driving market growth. Governments across the globe are dedicating significant funds to enhance healthcare infrastructure, expand medical services accessibility, and support research and innovation. This creates a favorable environment for the adoption of advanced medical devices like catheters. Additionally, private healthcare providers and investors are actively investing in the advancement and market introduction of innovative catheter technologies, contributing to market expansion. The increasing global healthcare expenditure, coupled with favorable reimbursement policies, also boosts demand for catheters and promotes market growth.

Integration of Digitalization

The integration of digital technologies in healthcare is transforming the catheters market. Digitalization enables remote monitoring of catheterized patients, real-time data collection, and analysis, enhancing patient care and clinical decision-making. For instance, in the Optica Publishing Group Magazine Biomedical Optics Express, researchers brought brand new catheter-based device images of heart disorder plaques with unheard-of detail. They describe their new flexible tool, which mixes fluorescence lifetime imaging (FLIM) and polarization-touchy optical coherence tomography (PSOCT) to seize rich information approximately about the composition, morphology, and microstructure of atherosclerotic plaques.

Opportunities to Cater Untapped Market

The market offers significant opportunities to serve various market segments. Furthermore, the increasing elderly population and the rise in chronic diseases worldwide are driving the demand for catheters among different demographic groups. Moreover, the development of healthcare facilities in developing countries provides profitable chances for market growth. Companies can take advantage of these opportunities by creating cost-effective and easily accessible catheter solutions that meet the unique requirements of different regions and patient populations. Additionally, there is a growing recognition of the significance of catheterization procedures in veterinary medicine, which is creating a new market for catheters in the veterinary sector.

Key Technological Trends & Development:

AI-Aided Geometric Design of Anti-Infection Catheters

The use of AI in the geometric design of anti-infection catheters transforms catheter technology by enhancing infection prevention. Producers can optimize the design to minimize areas prone to bacterial colonization, reducing the risk of catheter-associated infections (CAIs), by employing AI algorithms. According to the Centers for Disease Control and Prevention (CDC), estimated that about 75% are associated with a urinary catheter. Urinary catheters are provided to 15–25% of hospitalized patients during their stay, and due to the prolonged usage of the catheter, these patients are susceptible to catheter-associated UTIs (CAUTIs). Catheters can be designed with AI-assisted characteristics that encourage antimicrobial qualities and inhibit bacterial adhesion, improving patient outcomes and lessening the strain on healthcare systems. AI also makes it easier to quickly iterate and customize catheter designs depending on patient-specific parameters, which results in more individualized therapy.

Intermittent Catheterization Coating Technology

Intermittent catheterization coating technology represents a breakthrough in catheter materials, enhancing patient comfort and reducing the risk of complications. By incorporating specialized coatings, such as hydrophilic or antimicrobial coatings, manufacturers can improve lubrication, reduce friction during insertion, and inhibit microbial growth on the catheter surface. This technology is particularly beneficial for individuals requiring long-term catheterization, such as those with neurogenic bladder dysfunction or urinary retention. Studies have shown that coated catheters significantly reduce the incidence of urinary tract infections compared to uncoated catheters. For instance, in September Convatec introduced the GentleCath range of catheters, which features pioneering FeelClean^TM Technology, a groundbreaking innovation.  It uses a next-generation material in GentleCathTM catheters with FeelCleanTM Technology which is naturally slick when wet, negating the need for a coating. They reduce the risk of trauma or bleeding and the associated pain, as they have low friction levels during insertion.

Microelectronic Catheter for Minimally Invasive Surgery

The development of microelectronic catheters represents a groundbreaking innovation in minimally invasive surgical procedures. These catheters incorporate miniature electronic components, such as sensors and actuators, enabling real-time monitoring and manipulation within the body. By integrating diagnostic and therapeutic capabilities into a single device, microelectronic catheters streamline surgical workflows and enhance precision. They allow surgeons to perform complex procedures with greater accuracy and control, reducing tissue damage and recovery times for patients. As a result, microelectronic catheters are revolutionizing various medical specialties, including cardiology, gastroenterology, and neurosurgery, by enabling safer and more effective minimally invasive interventions.

Biosense Webster, Inc. launched OPTRELL Mapping Catheter with TRUEref™ Technology

In July 2023, Biosense Webster's introduced a new OPTRELL mapping catheter that aids in the delivery of high-definition electrophysiological mapping of complex cardiac arrhythmia cases. Additionally, the company secured 510(k) clearance from the United States Food and Drug Administration for the mapping catheter. The high-density diagnostic catheter is powered by the CARTO3 system and has tiny electrodes arranged in a fixed array arrangement to offer high-definition electrophysiological mapping of complex cardiac arrhythmia cases.  It also provides intelligent insights and high-resolution directional mapping.

Development of a Soft Robotic Catheter for Vascular Intervention Surgery

The development of soft robotic catheters offers a new era in vascular intervention surgery, offering enhanced flexibility, maneuverability, and safety. Unlike traditional rigid catheters, soft robotic catheters utilize flexible materials and advanced robotic technology to navigate complex vascular structures with greater precision. These catheters reduce the risk of vascular injury and improve procedural success rates, by mimicking the natural movements of soft tissue. Furthermore, soft robotic catheters enable access to previously inaccessible anatomical regions, expanding the scope of minimally invasive vascular interventions. Besides this, ISO 13485 certifications are granted to the organization that follows the requirements for quality management systems in the medical device industry. It is a standard specific to medical devices that ensure their safe and effective use.

Catheters Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, and end user.

Breakup by Type:

• • Cardiovascular Catheters
  • Urology Catheters
  • Intravenous Catheters
  • Neurovascular Catheters
  • Specialty Catheters
  • Others
     

Cardiovascular catheters account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes cardiovascular catheters, urology catheters, intravenous catheters, neurovascular catheters, specialty catheters, and others. According to the report, cardiovascular catheters represented the largest segment.

Cardiovascular catheters are specialized medical devices designed for diagnosing and treating cardiovascular conditions, including angioplasty, stent placement, and cardiac electrophysiology procedures. The prevalence of cardiovascular diseases globally and the continuous advancements in minimally invasive procedures are propelling the market growth. For instance, a shape-shifting robotic catheter can make heart surgery safer. In a paper published by Science Advance, the researchers demonstrated the robot’s ability to assist with two mock cardiac procedures using animal tissue. It is developed by a team of engineers and physicians at Boston University that allow shape-shafting robotic catheters to be maneuvered through complex anatomy while maintaining enough stability to accomplish surgical objectives.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others
   

Hospitals and clinics hold the largest share of the industry

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers, and others. According to the report, hospitals and clinics accounted for the largest market share.

Hospitals and clinics serve as primary points of care for patients requiring catheterization, thus driving substantial demand for these medical devices. Healthcare facilities rely on catheters for various procedures and treatments, including urinary catheterization, cardiovascular interventions, and intravenous therapy. The significant volume of patients treated in hospitals and clinics contributes to the high usage of catheters in these settings. Besides, the growing prevalence of urinary incontinence and an increasing number of surgical procedures are driving the adoption of catheters in hospitals. According to the National Institute of Health (NIH), prevalence and associated factors of urinary incontinence in women living in China: a literature review, the overall UI prevalence rates reported in adult Chinese women ranged from 8.7 to 69.8%, and for women aged 17-40 years, 41-59 years, and 60 years and older, prevalence rates ranged from 2.6-30.0, 8.7-47.7, to 16.9-61.6%, respectively.

Breakup by Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East
• Africa
   

North America leads the market, accounting for the largest catheters market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East, and Africa. According to the report, North America represents the largest regional market for catheters.

The market is driven by advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a growing geriatric population requiring catheterization procedures. As a result, manufacturers and stakeholders in the catheter industry prioritize strategies tailored to meet the specific needs and demands of this prominent market segment. Furthermore, with the ongoing developments and increasing awareness regarding catheter-based interventions, North America is poised to maintain its leading position in the global catheter market. For example, in November 2021, Flume Catheter Company Ltd. (TFCC), a prominent medical device company disclosed that FLUME catheter obtained clearance from the U.S. Food and Drug Administration (FDA) for marketing in the United States.

Analysis Covered Across Each Country:

• Historical, current, and future market performance
• Historical, current, and future performance of the market based on product, and end user.
• Competitive landscape
• Government regulations
   

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape covering market structure, market share by key players, market player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant, among others. Detailed profiles of all major companies have also been provided. This includes business overview, product offerings, business strategies, SWOT analysis, financials, and major news and events. Some of the major market players in the catheters industry include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Coloplast Corporation, ConvaTec Group PLC, Edwards Lifesciences Corporation, Hollister Incorporated, Johnson & Johnson, Medtronic plc, Stryker Corporation, and Teleflex Incorporated.

At present, major players in the industry are engaged in various activities to maintain and expand their market presence. These activities include research and development to innovate new products, strategic partnerships and collaborations to enhance their capabilities, mergers and acquisitions to strengthen their market position, and global expansion initiatives to tap into emerging markets. They are focusing on enhancing distribution networks, investing in marketing and promotional efforts to increase brand awareness and customer engagement, improving manufacturing processes, and following regulatory standards for medical devices. It includes the application of risk management to medical devices and quality management systems. Nowadays, key players are obtaining ISO 14971 certification, for medical devices, and application of risk management to medical devices. It is provided to manufacturers that implement, develop, and maintain the applicable regulatory requirements, that offer the development of numerous medical devices including implantable, and non-implantable medical devices, active, and non-active, software as medical devices, and in vitro diagnostic medical devices.
 

Analysis Covered for Each Player:

• Market Share
• Business Overview
• Products Offered
• Business Strategies
• SWOT Analysis
• Major News and Events
   

Catheters Market News:

• October 2023: B.Braun Medical Inc., a prominent leader in smart infusion therapy, disclosed the launch of their new Introcan Safety® 2 IV catheter with multi-access blood control. It offers a long line of passive needlestick prevention catheters, and automatic needlestick protection which minimizes the risk of bloodborne pathogen exposure throughout the IV process. 
• August 2023: Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the POLARx™ Cryoablation System. It is refined for addressing paroxysmal atrial fibrillation (AF) in patients and includes the POLARx FIT Cryoablation Balloon Catheter, which stands out for its ability to accommodate two balloon sizes 28mm and 31mm within a single device.
• November 2023: Becton, Dickinson, and business, a prominent global medical technology company introduced a new needle-free blood draw technology which is compatible with incorporated catheters.
   

Catheters Market Report Scope:

Key Questions Answered in This Report:

• How has the global catheters market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global catheters market?
• What is the impact of each driver, restraint, and opportunity on the global catheters market?
• What are the key regional markets?
• Which countries represent the most attractive catheters market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the catheters market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the catheters market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global catheters market?

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the catheters market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global catheters market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the catheters industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.